🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00461U105
- Market Cap
- Micro Cap
- IPO
- 10/6/2015 · $11.00/share
Business: Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing novel drugs to address unmet needs in dermatology.
Company Contact
- CEO
- Neal Walker
- CFO
- Kevin Balthaser
- Headquarters
- 701 Lee Road, Suite 103, Wayne, PA 19087
- Phone
- 484-324-7933
- Fax
- 484-320-2344
- Investor Relations
- Michael Tung · 484-329-2140 · mtung@aclaristx.com